Imaflex Capex To Depreciation vs Price To Sales Ratio Analysis

IFX Stock  CAD 1.40  0.03  2.10%   
Imaflex financial indicator trend analysis is infinitely more than just investigating Imaflex recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Imaflex is a good investment. Please check the relationship between Imaflex Capex To Depreciation and its Price To Sales Ratio accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Imaflex. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Capex To Depreciation vs Price To Sales Ratio

Capex To Depreciation vs Price To Sales Ratio Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Imaflex Capex To Depreciation account and Price To Sales Ratio. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Imaflex's Capex To Depreciation and Price To Sales Ratio is 0.46. Overlapping area represents the amount of variation of Capex To Depreciation that can explain the historical movement of Price To Sales Ratio in the same time period over historical financial statements of Imaflex, assuming nothing else is changed. The correlation between historical values of Imaflex's Capex To Depreciation and Price To Sales Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capex To Depreciation of Imaflex are associated (or correlated) with its Price To Sales Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Price To Sales Ratio has no effect on the direction of Capex To Depreciation i.e., Imaflex's Capex To Depreciation and Price To Sales Ratio go up and down completely randomly.

Correlation Coefficient

0.46
Relationship DirectionPositive 
Relationship StrengthWeak

Capex To Depreciation

The ratio of a company's capital expenditures to its depreciation expenses, indicating how much the company is investing in physical assets relative to the aging of existing assets.

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Imaflex stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Imaflex sales, a figure that is much harder to manipulate than other Imaflex multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.
Most indicators from Imaflex's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Imaflex current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Imaflex. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At this time, Imaflex's Sales General And Administrative To Revenue is fairly stable compared to the past year. Enterprise Value Over EBITDA is likely to climb to 8.69 in 2024, whereas Tax Provision is likely to drop slightly above 289.4 K in 2024.
 2021 2022 2023 2024 (projected)
Interest Expense411.4K449.4K593.9K610.3K
Depreciation And Amortization3.8M4.1M4.6M2.3M

Imaflex fundamental ratios Correlations

0.450.530.270.970.960.070.940.260.95-0.040.350.72-0.660.690.690.64-0.390.610.720.070.70.430.460.60.81
0.450.270.780.260.370.820.130.650.34-0.13-0.330.72-0.080.540.680.44-0.20.90.520.690.68-0.210.63-0.070.1
0.530.270.210.550.35-0.160.490.080.33-0.620.550.760.110.390.780.56-0.570.390.81-0.060.690.60.620.220.6
0.270.780.210.090.130.64-0.040.860.12-0.07-0.290.590.050.10.60.3-0.050.810.490.920.67-0.160.54-0.01-0.05
0.970.260.550.090.95-0.140.990.070.93-0.090.50.64-0.630.630.620.57-0.350.440.69-0.10.620.570.370.660.88
0.960.370.350.130.950.090.930.141.00.140.230.57-0.770.70.50.58-0.370.520.520.00.510.30.350.670.78
0.070.82-0.160.64-0.140.09-0.240.60.090.23-0.810.31-0.10.360.240.29-0.120.690.00.660.28-0.730.32-0.21-0.28
0.940.130.49-0.040.990.93-0.24-0.050.92-0.040.550.53-0.650.580.520.5-0.310.320.61-0.20.520.590.270.70.89
0.260.650.080.860.070.140.6-0.050.150.11-0.360.47-0.110.220.490.29-0.150.770.370.670.56-0.250.43-0.01-0.08
0.950.340.330.120.931.00.090.920.150.190.20.54-0.80.70.480.58-0.390.510.48-0.020.490.270.330.670.76
-0.04-0.13-0.62-0.07-0.090.140.23-0.040.110.19-0.52-0.47-0.580.02-0.48-0.030.01-0.04-0.540.05-0.39-0.55-0.330.17-0.19
0.35-0.330.55-0.290.50.23-0.810.55-0.360.2-0.520.210.07-0.020.29-0.02-0.06-0.230.53-0.430.220.990.090.270.58
0.720.720.760.590.640.570.310.530.470.54-0.470.21-0.050.630.950.67-0.330.820.90.340.910.330.810.290.6
-0.66-0.080.110.05-0.63-0.77-0.1-0.65-0.11-0.8-0.580.07-0.05-0.39-0.01-0.40.33-0.190.00.09-0.080.060.09-0.41-0.34
0.690.540.390.10.630.70.360.580.220.70.02-0.020.63-0.390.60.57-0.480.670.49-0.120.530.040.550.440.67
0.690.680.780.60.620.50.240.520.490.48-0.480.290.95-0.010.60.61-0.310.80.960.330.970.40.730.280.62
0.640.440.560.30.570.580.290.50.290.58-0.03-0.020.67-0.40.570.61-0.480.560.510.070.560.050.520.310.44
-0.39-0.2-0.57-0.05-0.35-0.37-0.12-0.31-0.15-0.390.01-0.06-0.330.33-0.48-0.31-0.48-0.32-0.230.16-0.24-0.04-0.38-0.16-0.3
0.610.90.390.810.440.520.690.320.770.51-0.04-0.230.82-0.190.670.80.56-0.320.660.620.82-0.10.730.250.36
0.720.520.810.490.690.520.00.610.370.48-0.540.530.90.00.490.960.51-0.230.660.230.940.630.660.340.7
0.070.69-0.060.92-0.10.00.66-0.20.67-0.020.05-0.430.340.09-0.120.330.070.160.620.230.43-0.320.3-0.08-0.24
0.70.680.690.670.620.510.280.520.560.49-0.390.220.91-0.080.530.970.56-0.240.820.940.430.340.660.320.59
0.43-0.210.6-0.160.570.3-0.730.59-0.250.27-0.550.990.330.060.040.40.05-0.04-0.10.63-0.320.340.190.280.61
0.460.630.620.540.370.350.320.270.430.33-0.330.090.810.090.550.730.52-0.380.730.660.30.660.190.210.39
0.6-0.070.22-0.010.660.67-0.210.7-0.010.670.170.270.29-0.410.440.280.31-0.160.250.34-0.080.320.280.210.8
0.810.10.6-0.050.880.78-0.280.89-0.080.76-0.190.580.6-0.340.670.620.44-0.30.360.7-0.240.590.610.390.8
Click cells to compare fundamentals

Imaflex Account Relationship Matchups

Imaflex fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets53.4M54.1M65.0M72.0M83.5M87.7M
Short Long Term Debt Total16.4M9.8M9.6M8.0M11.4M10.9M
Other Current Liab1.9M3.2M3.3M3.3M2.1M1.4M
Total Current Liabilities13.6M9.8M14.3M11.8M14.4M12.9M
Total Stockholder Equity29.7M36.0M45.1M55.1M55.9M58.7M
Property Plant And Equipment Net28.6M25.9M24.5M37.8M47.8M50.2M
Net Debt16.4M6.6M1.1M502.8K10.6M9.7M
Retained Earnings15.6M21.9M30.3M39.4M39.9M41.9M
Accounts Payable4.1M3.9M5.6M3.4M6.4M5.6M
Non Current Assets Total29.8M27.4M26.3M40.0M55.1M57.8M
Non Currrent Assets Other(2.2M)(1.5M)(3.3M)(3.4M)1.8M1.8M
Cash And Short Term Investments60.9K3.2M8.5M7.5M799.1K1.5M
Common Stock Shares Outstanding50.7M50.7M51.6M51.9M52.0M45.7M
Liabilities And Stockholders Equity53.4M54.1M65.0M72.0M83.5M87.7M
Non Current Liabilities Total10.1M8.3M5.6M5.1M13.2M6.7M
Inventory11.8M11.7M14.9M12.2M13.2M8.7M
Other Current Assets236.5K238.9K204.8K235.6K343.2K360.3K
Other Stockholder Equity1.6M1.7M2.2M3.1M1.00.95
Total Liab23.7M18.1M19.9M16.8M27.6M19.7M
Total Current Assets23.6M26.6M38.7M32.0M28.4M20.2M
Short Term Debt7.6M2.7M5.3M5.1M5.9M5.9M
Net Receivables11.5M11.5M15.1M12.1M14.1M10.5M
Cash60.9K3.2M8.5M7.5M799.1K1.5M
Accumulated Other Comprehensive Income597.6K484.6K2.2M3.1M3.0M3.1M
Other Liab1.2M1.2M1.4M2.1M2.4M1.5M
Net Tangible Assets28.5M34.4M43.3M52.9M60.9M30.7M
Good Will487.6K478.0K476.0K508.5K496.6K528.9K
Short Long Term Debt6.5M1.9M4.5M4.2M4.2M4.2M
Intangible Assets732.2K1.1M1.3M1.7M1.8M1.2M
Property Plant Equipment28.6M25.9M24.5M37.8M43.4M25.1M
Long Term Debt6.4M5.5M3.5M1.7M1.6M1.5M
Capital Lease Obligations3.5M2.4M1.6M2.1M7.2M7.6M
Net Invested Capital42.6M43.4M53.1M61.0M60.1M52.7M
Net Working Capital10.0M16.8M24.4M20.3M14.0M16.6M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Imaflex Stock Analysis

When running Imaflex's price analysis, check to measure Imaflex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Imaflex is operating at the current time. Most of Imaflex's value examination focuses on studying past and present price action to predict the probability of Imaflex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Imaflex's price. Additionally, you may evaluate how the addition of Imaflex to your portfolios can decrease your overall portfolio volatility.